-
1.
公开(公告)号:US20120252796A1
公开(公告)日:2012-10-04
申请号:US13498705
申请日:2010-09-29
IPC分类号: A61K31/422 , C07D405/06 , A61K31/403 , C07D413/14 , G01N33/53 , A61K31/496 , C07D417/14 , A61K31/541 , A61P3/06 , C07D413/06 , A61K31/5377
CPC分类号: C07D413/06 , C07D405/06 , C07D413/14 , C07D417/06 , C07D417/14
摘要: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
摘要翻译: 本发明涉及通式(I)的化合物,其互变异构形式,其立体异构体,其药学上可接受的盐,含有它们的药物组合物,其制备方法,这些化合物在医药中的用途以及参与其制备的中间体。